Isaac E.  Ciechanover net worth and biography

Isaac Ciechanover Biography and Net Worth

Dr. Isaac Ciechanover is a partner at Polaris, an investment firm that partners with entrepreneurs in healthcare and technology. He joined the firm in 2020 after six years as CEO of Atara Biotherapeutics.

Dr. Ciechanover founded the company in 2012 in honor of his mother, Atara, who passed away from cancer. Atara pioneers T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies. During his tenure as CEO, Dr. Ciechanover led the organization through its IPO and to a valuation over $1 billion. 

Previously, he served as a partner in the life sciences practice at Kleiner Perkins Caufield & Byers and in business development positions at Celgene and Amylin Pharmaceuticals. His first foray into venture capital was at the New York firm, Pequot Ventures, right after earning his M.B.A. from Harvard University. 

Dr. Ciechanover holds his B.A. in psychology from Stanford, his M. Phil in epidemiology from Cambridge University, and his M.D. from Cornell University’s Weill Medical College.

He is currently based in San Francisco.

What is Isaac E. Ciechanover's net worth?

The estimated net worth of Isaac E. Ciechanover is at least $230,576.64 as of May 30th, 2019. Dr. Ciechanover owns 332,243 shares of Atara Biotherapeutics stock worth more than $230,577 as of March 29th. This net worth approximation does not reflect any other assets that Dr. Ciechanover may own. Learn More about Isaac E. Ciechanover's net worth.

How do I contact Isaac E. Ciechanover?

The corporate mailing address for Dr. Ciechanover and other Atara Biotherapeutics executives is 611 GATEWAY BLVD SUITE 900, SOUTH SAN FRANCISCO CA, 94080. Atara Biotherapeutics can also be reached via phone at (805) 623-4211 and via email at [email protected]. Learn More on Isaac E. Ciechanover's contact information.

Has Isaac E. Ciechanover been buying or selling shares of Atara Biotherapeutics?

Isaac E. Ciechanover has not been actively trading shares of Atara Biotherapeutics during the last quarter. Most recently, Isaac E. Ciechanover sold 5,850 shares of the business's stock in a transaction on Thursday, May 30th. The shares were sold at an average price of $23.09, for a transaction totalling $135,076.50. Following the completion of the sale, the chief executive officer now directly owns 332,243 shares of the company's stock, valued at $7,671,490.87. Learn More on Isaac E. Ciechanover's trading history.

Who are Atara Biotherapeutics' active insiders?

Atara Biotherapeutics' insider roster includes Isaac Ciechanover (CEO), Jakob Dupont (EVP), Matthew Fust (Director), Utpal Koppikar (CFO), K. Murugan (SVP), Joe Newell (Insider), Thomas Peterffy (Chairman), Pascal Touchon (CEO), and Kristin Yarema (Insider). Learn More on Atara Biotherapeutics' active insiders.

Are insiders buying or selling shares of Atara Biotherapeutics?

During the last year, Atara Biotherapeutics insiders bought shares 2 times. They purchased a total of 279,020 shares worth more than $64,384.40. During the last year, insiders at the biotechnology company sold shares 12 times. They sold a total of 184,801 shares worth more than $237,993.35. The most recent insider tranaction occured on March, 4th when CEO Pascal Touchon sold 24,844 shares worth more than $17,887.68. Insiders at Atara Biotherapeutics own 4.5% of the company. Learn More about insider trades at Atara Biotherapeutics.

Information on this page was last updated on 3/4/2024.

Isaac E. Ciechanover Insider Trading History at Atara Biotherapeutics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/30/2019Sell5,850$23.09$135,076.50332,243View SEC Filing Icon  
5/14/2019Sell7,800$24.61$191,958.00332,243View SEC Filing Icon  
4/26/2019Sell7,800$33.54$261,612.00332,243View SEC Filing Icon  
4/10/2019Sell3,900$37.04$144,456.00332,243View SEC Filing Icon  
3/29/2019Sell7,800$38.66$301,548.00332,243View SEC Filing Icon  
3/15/2019Sell7,800$39.48$307,944.00332,243View SEC Filing Icon  
2/28/2019Sell7,800$36.14$281,892.00332,243View SEC Filing Icon  
2/12/2019Sell7,800$38.77$302,406.00334,618View SEC Filing Icon  
1/24/2019Sell7,800$35.06$273,468.00433,111View SEC Filing Icon  
1/10/2019Sell7,800$34.55$269,490.00733,285View SEC Filing Icon  
12/28/2018Sell7,800$33.88$264,264.00733,285View SEC Filing Icon  
12/27/2018Sell3,900$33.05$128,895.00733,285View SEC Filing Icon  
12/13/2018Sell7,800$42.66$332,748.00733,285View SEC Filing Icon  
11/29/2018Sell7,800$40.39$315,042.00733,285View SEC Filing Icon  
11/14/2018Sell3,900$33.99$132,561.00733,285View SEC Filing Icon  
10/22/2018Sell3,900$33.78$131,742.00733,285View SEC Filing Icon  
10/5/2018Sell7,800$40.22$313,716.00733,285View SEC Filing Icon  
9/19/2018Sell7,800$39.81$310,518.00812,613View SEC Filing Icon  
9/7/2018Sell7,800$39.35$306,930.00812,613View SEC Filing Icon  
8/21/2018Sell7,800$36.37$283,686.00812,613View SEC Filing Icon  
8/7/2018Sell7,800$37.43$291,954.00812,613View SEC Filing Icon  
7/27/2018Sell7,800$38.00$296,400.00812,613View SEC Filing Icon  
7/10/2018Sell58,400$40.00$2,336,000.00812,613View SEC Filing Icon  
6/26/2018Sell4,400$40.31$177,364.00812,613View SEC Filing Icon  
6/6/2018Sell8,800$48.56$427,328.00812,613View SEC Filing Icon  
5/22/2018Sell8,800$51.74$455,312.00812,613View SEC Filing Icon  
5/10/2018Sell8,800$39.85$350,680.00812,613View SEC Filing Icon  
4/27/2018Sell8,800$42.46$373,648.00View SEC Filing Icon  
4/11/2018Sell4,400$40.82$179,608.00812,613View SEC Filing Icon  
3/26/2018Sell4,400$40.10$176,440.00206,478View SEC Filing Icon  
3/16/2018Sell8,800$42.13$370,744.00812,613View SEC Filing Icon  
3/12/2018Sell1,000$46.31$46,310.00812,613View SEC Filing Icon  
2/22/2018Sell17,800$44.65$794,770.00812,613View SEC Filing Icon  
2/20/2018Sell8,700$45.28$393,936.00812,613View SEC Filing Icon  
2/16/2018Sell20,000$46.92$938,400.00812,613View SEC Filing Icon  
2/14/2018Sell20,000$46.80$936,000.00808,675View SEC Filing Icon  
2/9/2018Sell8,800$37.44$329,472.00808,675View SEC Filing Icon  
1/26/2018Sell19,300$35.26$680,518.00743,675View SEC Filing Icon  
1/24/2018Sell48,500$34.58$1,677,130.00348,978View SEC Filing Icon  
1/22/2018Sell10,000$33.07$330,700.00348,978View SEC Filing Icon  
1/16/2018Sell600$30.38$18,228.00743,675View SEC Filing Icon  
1/12/2018Sell28,700$21.39$613,893.00743,675View SEC Filing Icon  
1/10/2018Sell8,600$19.99$171,914.00743,675View SEC Filing Icon  
12/29/2017Sell22,200$18.29$406,038.00View SEC Filing Icon  
12/28/2017Sell2,200$15.15$33,330.00743,675View SEC Filing Icon  
12/13/2017Sell4,400$14.65$64,460.00743,675View SEC Filing Icon  
11/30/2017Sell4,400$14.25$62,700.00View SEC Filing Icon  
11/14/2017Sell4,400$13.47$59,268.00737,767View SEC Filing Icon  
10/27/2017Sell4,400$13.59$59,796.00737,767View SEC Filing Icon  
10/12/2017Sell4,400$15.02$66,088.00View SEC Filing Icon  
10/11/2017Sell2,200$15.25$33,550.00737,767View SEC Filing Icon  
9/20/2017Sell4,400$15.54$68,376.00737,767View SEC Filing Icon  
9/7/2017Sell4,400$15.02$66,088.00737,767View SEC Filing Icon  
8/23/2017Sell4,400$13.54$59,576.00737,767View SEC Filing Icon  
8/11/2017Sell4,400$14.67$64,548.00731,859View SEC Filing Icon  
7/25/2017Sell5,500$16.49$90,695.00731,859View SEC Filing Icon  
7/24/2017Sell2,800$16.94$47,432.00731,859View SEC Filing Icon  
5/31/2017Sell6,900$13.35$92,115.00731,859View SEC Filing Icon  
5/30/2017Sell3,450$13.44$46,368.00731,859View SEC Filing Icon  
5/18/2017Sell4,800$14.91$71,568.00731,859View SEC Filing Icon  
4/26/2017Sell7,200$17.56$126,432.00725,951View SEC Filing Icon  
4/25/2017Sell3,600$17.33$62,388.00725,951View SEC Filing Icon  
4/11/2017Sell7,200$17.03$122,616.00725,951View SEC Filing Icon  
3/28/2017Sell16,000$20.06$320,960.00725,951View SEC Filing Icon  
3/17/2017Sell30,800$19.38$596,904.00725,951View SEC Filing Icon  
2/16/2017Sell4,800$15.56$74,688.00725,951View SEC Filing Icon  
2/3/2017Sell4,800$13.66$65,568.00555,044View SEC Filing Icon  
1/18/2017Sell6,000$14.24$85,440.00555,044View SEC Filing Icon  
1/6/2017Sell8,400$16.89$141,876.00555,044View SEC Filing Icon  
12/23/2016Sell4,800$15.22$73,056.00555,044View SEC Filing Icon  
12/7/2016Sell7,200$17.93$129,096.00555,044View SEC Filing Icon  
11/23/2016Sell12,000$18.34$220,080.00555,044View SEC Filing Icon  
11/22/2016Sell8,400$18.21$152,964.00555,044View SEC Filing Icon  
10/27/2016Sell4,800$13.81$66,288.00549,136View SEC Filing Icon  
10/14/2016Sell4,800$15.96$76,608.00549,136View SEC Filing Icon  
9/28/2016Sell12,000$20.87$250,440.00406,578View SEC Filing Icon  
9/16/2016Sell7,200$19.36$139,392.00229,136View SEC Filing Icon  
8/23/2016Sell9,600$22.33$214,368.00229,136View SEC Filing Icon  
7/21/2016Sell9,600$22.11$212,256.00223,228View SEC Filing Icon  
7/8/2016Sell9,600$22.88$219,648.00223,228View SEC Filing Icon  
6/24/2016Sell9,600$21.26$204,096.00223,228View SEC Filing Icon  
6/8/2016Sell12,000$20.53$246,360.00223,228View SEC Filing Icon  
6/7/2016Sell7,200$20.36$146,592.00223,228View SEC Filing Icon  
5/26/2016Sell7,200$17.69$127,368.00223,228View SEC Filing Icon  
4/26/2016Sell1,300$20.12$26,156.00217,321View SEC Filing Icon  
4/12/2016Sell13,210$20.40$269,484.00217,321View SEC Filing Icon  
4/1/2016Sell1,190$20.03$23,835.70217,321View SEC Filing Icon  
1/14/2016Sell2,400$20.20$48,480.0047,440View SEC Filing Icon  
12/31/2015Sell2,400$26.00$62,400.0047,440View SEC Filing Icon  
12/15/2015Sell2,400$22.46$53,904.0047,440View SEC Filing Icon  
12/4/2015Sell4,000$37.45$149,800.0047,440View SEC Filing Icon  
11/24/2015Sell4,800$35.03$168,144.0047,440View SEC Filing Icon  
10/22/2015Sell3,200$25.85$82,720.0041,532View SEC Filing Icon  
10/7/2015Sell4,000$33.08$132,320.0041,532View SEC Filing Icon  
9/24/2015Sell5,200$42.99$223,548.0041,532View SEC Filing Icon  
9/11/2015Sell5,200$46.16$240,032.0041,532View SEC Filing Icon  
8/28/2015Sell5,200$39.25$204,100.0041,532View SEC Filing Icon  
7/17/2015Sell5,200$60.71$315,692.00View SEC Filing Icon  
7/1/2015Sell5,200$50.42$262,184.00View SEC Filing Icon  
6/18/2015Sell5,200$54.72$284,544.00View SEC Filing Icon  
6/5/2015Sell6,400$42.91$274,624.00View SEC Filing Icon  
5/22/2015Sell4,000$37.56$150,240.00View SEC Filing Icon  
4/23/2015Sell5,200$61.36$319,072.00View SEC Filing Icon  
See Full Table

Isaac E. Ciechanover Buying and Selling Activity at Atara Biotherapeutics

This chart shows Isaac E Ciechanover's buying and selling at Atara Biotherapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Atara Biotherapeutics Company Overview

Atara Biotherapeutics logo
Atara Biotherapeutics, Inc. develops therapies for patients with solid tumors, hematologic cancers, and autoimmune diseases in the United States. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as nasopharyngeal carcinoma. Its CAR T immunotherapy pipeline products include ATA2271 and ATA3271 to treat mesothelin; and ATA3219 for the treatment of B-cell malignancies, as well as ATA188 that is in Phase 2 clinical trials to treat multiple sclerosis. Atara Biotherapeutics, Inc. has a license agreement with Memorial Sloan Kettering Cancer Center; license, and research and development collaboration agreement with QIMR Berghofer Medical Research Institute; and strategic collaboration with H. Lee Moffitt Cancer Center. The company was incorporated in 2012 and is headquartered in Thousand Oaks, California.
Read More

Today's Range

Now: $0.69
Low: $0.65
High: $0.72

50 Day Range

MA: $0.74
Low: $0.58
High: $1.22

2 Week Range

Now: $0.69
Low: $0.20
High: $3.08

Volume

1,203,893 shs

Average Volume

3,170,402 shs

Market Capitalization

$70.73 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.71